Get In Touch

Global Preventive Asthma Drugs Market: Overview

Asthma is a chronic lung disease characterized by narrowing of airways and continual, marked inflammation and in response to specific triggers, which are usually reversible. If the management of the conditions are not done properly, this may elevate the risk of asthma attacks and even medical emergencies. Most, if not all, asthma attacks are preventable, especially in adults. Notwithstanding this fact, world over there is a rising prevalence of asthma, which is closely linked to the severity and mortality of the disease. In particular, this is evident in developed nations such as the U.S.

Preventive drugs for asthma play a crucial role in managing the disease conditions and help pacify the risk of asthma attacks. Drug therapies for asthma have been evolving rapidly, driven by advances in pharmacotherapy of asthma. Research into expanding the various pathophysiologic processes related with asthmatic response and triggers will lead to advanced classes of asthma drugs with less toxicity. Rise in population with higher tobacco consumption and prolonged exposure to smoke of biomass fuels are adding to the prevalence of the disease.

The report offers critical assessment of key growth drivers, prominent trends, recent research and development activities, clinical advances, and the prevailing regulatory framework affecting product development in various countries. The insights help market players devise investment strategies and identify lucrative avenues.

Global Preventive Asthma Drugs Market: Trends and Opportunities

The rise in pollution levels in a number of industrialized nations has led to an increased presence of allergens triggering asthma. This is a key factor driving the demand for preventive asthma drugs. The rising incidence of asthma in various parts of emerging and developed economies, along with the morbidity associated with the disease, is a key factor accentuating the demand for preventive drugs. The plethora of simple diagnostics for asthma available in the market is a noteworthy factor favoring the growth of the market. The need for preventive classes of drugs to keep asthma triggers for patients in check is also boosting the market. The advent of potential class of drugs that reduces the mortality associated with asthma and help in reducing the inflammatory inflammations at bay is helping the market to expand rapidly.

However, lack of understanding of etiology of the disease is proving to be a bottleneck in the development of new drugs. The paucity of novel class of antiasthma therapies is also hindering the market’s growth. Nevertheless, advances in pathophysiology and pharmacology augurs well for the market. Research and development (R&D) activities into new class of corticosteroids especially known for their wide therapeutic benefits bode well for the overall market. 

Global Preventive Asthma Drugs Market: Regional Outlook

Some of the key regional markets for asthma drugs can be North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Of all the major region, North America is poised to contribute substantial revenue throughout the forecast period. A robust medical infrastructure and the elevated awareness about the disease are notable factors boosting the demand. The intensifying demand among patients for more efficacious drugs to manage the conditions of asthma is expected to accentuate the growth of the regional market.

Asia Pacific is offering potentially lucrative avenues in the market. The population in various urban parts of Asia Pacific, particularly in Southeast Asia, is causing incidence of asthma to soar in the region, thereby favoring the growth of the market. The attractive stride being taken by contract manufacturing industry in the region is also fueling the growth.

Companies mentioned in the report        

Top drug makers are making sizeable investments in clinical trials focused on reducing asthma exacerbations, in a move to develop advanced and more efficacious drugs for managing asthma. Players holding a position of prominence in the preventive asthma drugs market include Mylan N.V., Abbott Laboratories, Bushranger Ingelheim, F. Hoffmann-La Roche, Merck & Co., AstraZeneca plc, GlaxoSmithKline plc, and Novartis AG.

This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.

Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:

  • Customer Experience Maps
  • Insights and Tools based on data-driven research
  • Actionable Results to meet all the business priorities
  • Strategic Frameworks to boost the growth journey

The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.

The following regional segments are covered comprehensively:

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • The Middle East and Africa

The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.

Below is a snapshot of these quadrants.

1. Customer Experience Map

The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.

2. Insights and Tools

The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.

3. Actionable Results

The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.

4. Strategic Frameworks

The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.

The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:

1. What can be the best investment choices for venturing into new product and service lines?

2. What value propositions should businesses aim at while making new research and development funding?

3. Which regulations will be most helpful for stakeholders to boost their supply chain network?

4. Which regions might see the demand maturing in certain segments in near future?

5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?

6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?

7. Which government regulations might challenge the status of key regional markets?

8. How will the emerging political and economic scenario affect opportunities in key growth areas?

9. What are some of the value-grab opportunities in various segments?

10. What will be the barrier to entry for new players in the market?

Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

Custom Market Research Services

TMR offers custom market research services that help clients to get information on their business scenario required where syndicated solutions are not enough.

REQUEST CUSTOMIZATION

Preventive Asthma Drugs Market

Pre Book